United States Últimas notícias

Figure Technology Solutions (NASDAQ:FIGR) announced a definitive agreement to acquire Kiavi, an AI-powered lending platform tailored for residential real estate investors, in a transaction valued at $717 million.

Scinai Immunotherapeutics (NASDAQ:SCNI) reported a net profit for the first quarter of fiscal year 2026, driven primarily by a substantial, non-cash accounting gain linked to its recent acquisition of Recipharm Israel.

Cullinan Therapeutics (NASDAQ:CGEM) reported encouraging initial clinical data and outlined expanded development pathways for its portfolio of dual-targeting T-cell engagers, marking an expansion for the oncology-focused biotech into the autoimmune space.

Taiwan Semiconductor Manufacturing Co. reported monthly sales rose 30%, reflecting continued strength in global demand spurred by a rush to build AI infrastructure. Neil Campling reports on Bloomberg Television.

Artelo Biosciences (NASDAQ:ARTL) announced encouraging human metabolite identification and profiling data for its lead drug candidate, ART26.12, as the biotechnology company aims to de-risk the development of its novel non-opioid pain therapy.

Organon (NYSE:OGN) announced that the US Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) for Tofidence, expanding the therapeutic indications of the drug within the competitive US biosimilars market.

President Donald Trump posted a warning on social media Wednesday that Iran has taken too long to come to terms and will "pay the price." Tyler Kendall reports on Bloomberg Television.

Core & Main (NYSE:CNM) reported improved financial results for the first quarter of fiscal year 2026, supported by reliable infrastructure demand and active cost navigation in an otherwise mixed industrial environment.

Nvni Group (NASDAQ:NVNI) announced substantial progress toward completing its acquisition of a 51% controlling interest in the holding company operating Beyondsoft Corporation’s consulting and services business across the United States, Brazil, and Singapore.

Tecnoglass (NYSE:TLGS) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.15 per share for the second quarter of 2026.

Harrow (NASDAQ:HROW) announced the formal commercial re-launch of Verkazia, a targeted prescription therapy for vernal keratoconjunctivitis (VKC), an underdiagnosed but severe chronic allergic eye disease that primarily affects children.

Chewy (NYSE:CHWY) delivered a strong financial performance for the first quarter of fiscal year 2026, characterized by robust top-line growth and a significant increase in profitability despite a dynamic broader consumer environment.